Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Chee Gee See, Jeffrey Bishop, Linda Greub

Premium

Proteome Sciences said this week it had appointed Chee Gee See director of personalized medicine.

Previously Gee See was a biomarker and experimental medicine leader at Roche. Before that he was an analyst at GlaxoSmithKline.


Singulex said this week that it has appointed Jeffrey Bishop vice president, research and development and Linda Greub vice president, business development.

Bishop was previously vice president, research and development at Alere.

Greub was previously global director of strategy, business development at Novartis. Prior to that she was senior director, strategy and business development at Applied Biosystems as well as a senior healthcare analyst for several investment banks and hedge funds.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.